267 related articles for article (PubMed ID: 31713180)
1. Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis.
Mulholland BS; Forwood MR; Morrison NA
Curr Osteoporos Rep; 2019 Dec; 17(6):538-547. PubMed ID: 31713180
[TBL] [Abstract][Full Text] [Related]
2. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
[TBL] [Abstract][Full Text] [Related]
3. A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone.
Li X; Loberg R; Liao J; Ying C; Snyder LA; Pienta KJ; McCauley LK
Cancer Res; 2009 Feb; 69(4):1685-92. PubMed ID: 19176388
[TBL] [Abstract][Full Text] [Related]
4. PTHrP-induced MCP-1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitro.
Lu Y; Xiao G; Galson DL; Nishio Y; Mizokami A; Keller ET; Yao Z; Zhang J
Int J Cancer; 2007 Aug; 121(4):724-33. PubMed ID: 17390372
[TBL] [Abstract][Full Text] [Related]
5. Monocyte chemoattractant protein-1 is a mediator of the anabolic action of parathyroid hormone on bone.
Tamasi JA; Vasilov A; Shimizu E; Benton N; Johnson J; Bitel CL; Morrison N; Partridge NC
J Bone Miner Res; 2013 Sep; 28(9):1975-86. PubMed ID: 23519994
[TBL] [Abstract][Full Text] [Related]
6. Constitutively active parathyroid hormone receptor signaling in cells in osteoblastic lineage suppresses mechanical unloading-induced bone resorption.
Ono N; Nakashima K; Schipani E; Hayata T; Ezura Y; Soma K; Kronenberg HM; Noda M
J Biol Chem; 2007 Aug; 282(35):25509-16. PubMed ID: 17500070
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts.
Li X; Qin L; Bergenstock M; Bevelock LM; Novack DV; Partridge NC
J Biol Chem; 2007 Nov; 282(45):33098-106. PubMed ID: 17690108
[TBL] [Abstract][Full Text] [Related]
8. Advances in the biology of bone metastasis: how the skeleton affects tumor behavior.
Sterling JA; Edwards JR; Martin TJ; Mundy GR
Bone; 2011 Jan; 48(1):6-15. PubMed ID: 20643235
[TBL] [Abstract][Full Text] [Related]
9. Catabolic Effects of Human PTH (1-34) on Bone: Requirement of Monocyte Chemoattractant Protein-1 in Murine Model of Hyperparathyroidism.
Siddiqui JA; Johnson J; Le Henaff C; Bitel CL; Tamasi JA; Partridge NC
Sci Rep; 2017 Nov; 7(1):15300. PubMed ID: 29127344
[TBL] [Abstract][Full Text] [Related]
10. PTHrP regulates angiogenesis and bone resorption via VEGF expression.
Isowa S; Shimo T; Ibaragi S; Kurio N; Okui T; Matsubara K; Hassan NM; Kishimoto K; Sasaki A
Anticancer Res; 2010 Jul; 30(7):2755-67. PubMed ID: 20683010
[TBL] [Abstract][Full Text] [Related]
11. Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption.
Lu Y; Cai Z; Xiao G; Keller ET; Mizokami A; Yao Z; Roodman GD; Zhang J
Cancer Res; 2007 Apr; 67(8):3646-53. PubMed ID: 17440076
[TBL] [Abstract][Full Text] [Related]
12. Osteoblastic monocyte chemoattractant protein-1 (MCP-1) mediation of parathyroid hormone's anabolic actions in bone implicates TGF-β signaling.
Siddiqui JA; Le Henaff C; Johnson J; He Z; Rifkin DB; Partridge NC
Bone; 2021 Feb; 143():115762. PubMed ID: 33212319
[TBL] [Abstract][Full Text] [Related]
13. Colony stimulating factor-1 plays a role in osteoclast formation and function in bone resorption induced by parathyroid hormone and parathyroid hormone-related protein.
Weir EC; Lowik CW; Paliwal I; Insogna KL
J Bone Miner Res; 1996 Oct; 11(10):1474-81. PubMed ID: 8889847
[TBL] [Abstract][Full Text] [Related]
14. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
15. MAPK11 in breast cancer cells enhances osteoclastogenesis and bone resorption.
He Z; He J; Liu Z; Xu J; Yi SF; Liu H; Yang J
Biochimie; 2014 Nov; 106():24-32. PubMed ID: 25066918
[TBL] [Abstract][Full Text] [Related]
16. The expression of monocyte chemoattractant protein-1 and other chemokines by osteoblasts.
Graves DT; Jiang Y; Valente AJ
Front Biosci; 1999 Jul; 4():D571-80. PubMed ID: 10393126
[TBL] [Abstract][Full Text] [Related]
17. CCL2/Monocyte Chemoattractant Protein 1 and Parathyroid Hormone Action on Bone.
Siddiqui JA; Partridge NC
Front Endocrinol (Lausanne); 2017; 8():49. PubMed ID: 28424660
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
[TBL] [Abstract][Full Text] [Related]
19. PTHrP(12-48) Modulates the Bone Marrow Microenvironment and Suppresses Human Osteoclast Differentiation and Lifespan.
Kamalakar A; Washam CL; Akel NS; Allen BJ; Williams DK; Swain FL; Leitzel K; Lipton A; Gaddy D; Suva LJ
J Bone Miner Res; 2017 Jul; 32(7):1421-1431. PubMed ID: 28370412
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone-related protein and bone metastases.
Guise TA
Cancer; 1997 Oct; 80(8 Suppl):1572-80. PubMed ID: 9362424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
